China accepts cluster of complaints under new patent linkage law

09-11-2021

Muireann Bolger

China accepts cluster of complaints under new patent linkage law

The China National Intellectual Property Administration (CNIPA) has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021. The office confirmed the development in a statement released on October 29.


China, complaints, patent, linkage, drug, companies, resolution, dispute

LSIPR